Prudential Financial Inc Intellia Therapeutics, Inc. Transaction History

Prudential Financial Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$20.02 - $27.22 $5,965 - $8,111	298 Added 1.27%	23,739 $531,000
Q1 2024 May 14, 2024	BUY	$23.82 - $32.8 $372,354 - $512,729	15,632 Added 200.18%	23,441 $644,000
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $2,895 - $4,042	125 Added 1.63%	7,809 $238,000
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $15,778 - $22,844	499 Added 6.95%	7,684 $242,000
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $19,641 - $26,145	568 Added 8.58%	7,185 $293,000
Q1 2023 May 12, 2023	SELL	$33.3 - $44.82 $3,829 - $5,154	-115 Reduced 1.71%	6,617 $246,000
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $6,774 - $12,788	204 Added 3.13%	6,732 $0
Q3 2022 Nov 04, 2022	BUY	$53.92 - $71.7 $7,602 - $10,109	141 Added 2.21%	6,528 $361,000
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $637,702 - $1.26 Million	-16,568 Reduced 72.18%	6,387 $335,000
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $4.02 Million - $8.2 Million	-68,927 Reduced 75.02%	22,955 $1.67 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $2.53 Million - $3.47 Million	25,060 Added 37.5%	91,882 $11 Million
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $49,506 - $66,115	-374 Reduced 0.56%	66,822 $9.11 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $596,136 - $1.59 Million	9,792 Added 17.06%	67,196 $10.9 Million
Q1 2021 May 12, 2021	BUY	$46.59 - $83.68 $2.44 Million - $4.39 Million	52,470 Added 1063.44%	57,404 $4.61 Million
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $92,907 - $313,457	4,934 New	4,934 $268,000

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $929M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.